`______________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________________
`
`REGENERON PHARMACEUTICALS, INC.,
`Petitioner,
`
`v.
`
`NOVARTIS PHARMA AG,
`NOVARTIS TECHNOLOGY LLC,
`NOVARTIS PHARMACEUTICALS CORPORATION,
`Patent Owner.
`
`________________________
`
`Case IPR2021-00816
`U.S. Patent No. 9,220,631 B2
`________________________
`
`PETITIONER’S UPDATED POWER OF ATTORNEY
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.10(b), Petitioner Regeneron Pharmaceuticals,
`
`Inc. hereby appoints the following practitioners as their attorneys to transact all
`
`business in the United States Patent & Trademark Office connected to the above
`
`captioned Inter Partes Review of U.S. Patent No. 9,220,631:
`
`Lead Counsel
`Elizabeth Stotland Weiswasser
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8022
`F: 212-310-8007
`elizabeth.weiswasser@weil.com
`USPTO Reg. No. 55,721
`
`
`Back-Up Counsel
`Anish R. Desai
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8730
`F: 212-310-8007
`anish.desai@weil.com
`USPTO Reg. No. 73,760
`
`Christopher M. Pepe
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, D.C. 20036
`T: 202-682-7000
`F: 202-857-0940
`christopher.pepe@weil.com
`USPTO Reg. No. 73,851
`
`Robert T. Vlasis
`Admitted Pro Hac Vice (Updated)
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, D.C. 20036
`T: 202-682-7000
`F: 202-857-0940
`robert.vlasis@weil.com
`
`Matthew D. Sieger (Updated)
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, D.C. 20036
`
`
`
`1
`
`
`
`
`
`
`
`
`
`
`T: 202-682-7000
`F: 202-857-0940
`matthew.sieger@weil.com
`USPTO Reg. No. 76,051
`
`Natalie Kennedy
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8730
`F: 212-310-8007
`natalie.kennedy@weil.com
`USPTO Reg. No. 68,511
`
`Andrew Gesior
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8730
`F: 212-310-8007
`andrew.gesior@weil.com
`USPTO Reg. No. 76,588
`
`Petra Scamborova
`Admitted Pro Hac Vice
`Regeneron Pharmaceuticals, Inc.
`777 Old Saw Mill River Road
`Tarrytown, NY 10591
`914-847-7611
`petra.scamborova@regeneron.com
`
`James T. Evans
`Regeneron Pharmaceuticals, Inc.
`777 Old Saw Mill River Road
`Tarrytown, NY 10591
`914-847-7000
`james.evans@regeneron.com
`USPTO Reg. No. 64,377
`
`2
`
`
`
`
`
`
`
`
`
`
`
`
`
`The undersigned has the authority to execute this document on behalf of
`
`
`
`
`
`Regeneron Pharmaceuticals, Inc.
`
`Date: February 15, 2022
`
`<�Cky
`
`Vice President,
`
`
`Associate General Counsel
`
`
`Regeneron Pharmaceuticals, Inc.
`
`3
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that on February 15, 2022, the
`
`foregoing PETITIONER’S UPDATED POWER OF ATTORNEY was
`
`served via electronic mail upon the following:
`
`Elizabeth J. Holland
`Linnea Cipriano
`Goodwin Procter LLP
`620 Eighth Avenue
`New York, NY 10018
`EHolland@goodwinlaw.com
`LCipriano@goodwinlaw.com
`
`William G. James
`Goodwin Procter LLP
`1900 N Street, N.W.
`Washington, D.C. 20036
`WJames@goodwinlaw.com
`
`Joshua Weinger
`Nicholas K. Mitrokostas
`Goodwin Procter LLP
`100 Northern Avenue
`Boston, MA 02210
`JWeinger@goodwinlaw.com
`nmitrokostas@goodwinlaw.com
`
`DG-NovartisPFS@goodwinlaw.com
`
`/Lauren McDuffie/
`Lauren McDuffie
`Senior IP Paralegal
`Weil, Gotshal & Manges LLP
`2001 M Street, NW, Suite 600
`Washington, D.C. 20036
`T: 202-682-7000
`lauren.mcduffie@weil.com
`
`4
`
`